{"id":"W2167567290","doi":"10.1016/s1474-4422(14)70198-x","title":"Safety and efficacy of idalopirdine, a 5-HT 6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial","year":2014,"lang":"en","type":"article","venue":"The Lancet Neurology","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Donepezil; Placebo; Medicine; Clinical endpoint; Montreal Cognitive Assessment; Internal medicine; Alzheimer's disease; Clinical trial; Randomized controlled trial; Disease; Dementia; Pathology","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009436375,0.0002088401,0.0009898667,0.0001320982,0.00008697146,0.00002139022,0.0001469464,0.00006473514,0.0001074869],"category_scores_gemma":[0.0002415984,0.0001208674,0.00009008917,0.0001606877,0.0002620657,0.00005607054,0.00006954246,0.0003337854,0.000008384892],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006981053,"about_ca_system_score_gemma":0.00009886231,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001669516,"about_ca_topic_score_gemma":0.000009759783,"domain_scores_codex":[0.9977563,0.0006867396,0.000439117,0.0003594884,0.0003208715,0.0004374802],"domain_scores_gemma":[0.9985196,0.0006517714,0.0001761376,0.0003589119,0.0001144595,0.0001791246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9727688,0.001277495,0.02247771,0.00002538331,0.0002963651,0.00001667165,0.00006790757,0.00002412004,0.00005866462,0.0001034836,0.0001308419,0.002752582],"study_design_scores_gemma":[0.943119,0.006005167,0.04793678,0.00002254483,0.0004772579,0.000003094108,0.000003613903,0.001507196,0.00009176771,0.00003949396,0.0006866576,0.0001074475],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9882455,0.0001116021,0.0001156168,0.004736913,0.0000864927,0.005661239,0.00002268083,0.00002578307,0.0009942147],"genre_scores_gemma":[0.998027,0.00007052642,0.00001710306,0.001170748,0.0002563382,0.0003025268,0.00007144848,0.00002371201,0.00006063185],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02964979,"threshold_uncertainty_score":0.492883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02550439855798756,"score_gpt":0.3142197630202742,"score_spread":0.2887153644622866,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}